Search

EHA-SIE joint membership

Save money and time money by becoming a joint member of EHA and the Società Italiana di Ematologia. We've joined forces with the Società Italiana di Ematologia (SIE) to offer a special joint membership deal.

Read more

EHA-SSH joint membership

Save money and time by becoming a joint member of EHA and the Swiss Society of Hematology. We've joined forces with the Swiss Society of Hematology (SSH) to offer a special joint membership deal.

Read more

Targeting the B-cell Receptor in Aggressive B-cell Lymphomas

In collaboration with Dr. Lou Staudt, Pharmacyclics and associate investigators, we performed a clinical trial of a very potent inhibitor of Bruton Tyrosine Kinase (BTK) called ibrutinib.

Read more

Streamlining SoHO Management in EU Hospitals

The European Commission's Directorate-General for Health and Food Safety (DG SANTE) is committed to improving the management of Substances of Human Origin (SoHO) in EU hospitals.

Read more

Young EHA Committee

Current committee members
Nuno Borges, United Kingdom (Chair)
Alba Maiques Diaz, Spain (Vice-Chair)
Elizabeth Macintyre, France (EHA Past President)
Regular members
Anna Avagyan, Armenia 
Côme Bommier, France
Lorenzo Brunetti, Italy
Ana Filipa Marques Saraiva, Portugal
Eleni Gavriilaki, Greece
Ruxandra Irimia, Romania
Rafal Machowicz, Poland
Pedro Moura, Sweden
Rhiannon Newman, Finland
Marlies Vanden Bempt, Belgium
Carlo…

Read more

Starting this November: EHA Guidelines Workshops!

EHA has initiated a series of online workshops dedicated to guidelines (produced or endorsed by EHA) for diagnosis and treatment of hematologic diseases.

Read more

Challenging the safety of conformity: Better poster design to disseminate scientific knowledge fast

“Congratulations – your abstract was accepted for the upcoming EHA congress”.

Read more

EHA Guidelines by Topic

AL Amyloidosis
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines (2021)
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group (2022)
Anemia
Recommendations regarding splenectomy in hereditary hemolytic anemias (2017)
Management of…

Read more

EMA Issues Call for Expressions of Interest for Drug Safety Studies

The purpose of this call is to enable the EMA to obtain fast and reliable answers to questions on safety or benefit/risk concerns, and ultimately facilitating regulatory decision-making.

Read more